GLY-ARG-ARG-ALA-ALA-PRO-GLY-ARG-AIB-GLY-GLY-NH2

Substance Class	Protein Created by `admin` on `Wed Apr 02 11:35:31 GMT 2025` Edited by `admin` on `Wed Apr 02 11:35:31 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	4SS6E3D7MH
Record Status	`FAILED`
Record Version

Name

Type

Language

Systematic Name

English

GLYCYL-L-ARGINYL-L-ARGINYL-L-ALANYL-L-ALANYL-L-PROLYLGLYCYL-L-ARGINYL-2-METHYLALANYLGLYCYLGLYCINAMIDE

Preferred Name

English

GLYCINAMIDE, GLYCYL-L-ARGINYL-L-ARGINYL-L-ALANYL-L-ALANYL-L-PROLYLGLYCYL-L-ARGINYL-2-METHYLALANYLGLYCYL-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

810621

Created by admin on Wed Apr 02 11:35:31 GMT 2025 , Edited by admin on Wed Apr 02 11:35:31 GMT 2025

Code System Code Type Description

PUBCHEM

155801584

Created by admin on Wed Apr 02 11:35:31 GMT 2025 , Edited by admin on Wed Apr 02 11:35:31 GMT 2025

PRIMARY

CAS

1145786-97-5

Created by admin on Wed Apr 02 11:35:31 GMT 2025 , Edited by admin on Wed Apr 02 11:35:31 GMT 2025

PRIMARY

FDA UNII

4SS6E3D7MH

Created by admin on Wed Apr 02 11:35:31 GMT 2025 , Edited by admin on Wed Apr 02 11:35:31 GMT 2025

PRIMARY

Related Record Type Details


					4SS6E3D7MH

ACTIVE MOIETY

Comments:

Invention provides a method of inhibiting degeneration of cells of the retina

Amount:

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_9]	SITE_SPECIFIC		Amount:	.ALPHA.-AMINOISOBUTYRIC ACID	1E7ZW41IQU
AMINO_ACID_SUBSTITUTION	[1_11]	C-TERMINUS		Amount:	GLYCINAMIDE	4JDT453NWO

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL

Molecular Formula	CHEMICAL